EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Susceptibility of Brca1 ( L63X/+ ) rat to ovarian reserve dissipation by chemotherapeutic agents to breast cancer

Satoshi Kaseki, Reina Sonehara, Yashiro Motooka iD, Hideaki Tanaka, Tomoko Nakamura, Satoko Osuka, Shinya Akatsuka, Hiroaki Kajiyama iD, Tomoji Mashimo, Tatsuhiko Imaoka iD, Shinya Toyokuni iD

Cancer Science · 2025-04 · 116 (4) · 1139-1152

DOI: 10.1111/cas.16412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 03.02.2025. Verfasst von Satoshi Kaseki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Ovarian Reserve, Phthalazines, BRCA1 Protein, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Core Research for Evolutional Science and Technology, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRCA1 is one of the causative genes for hereditary breast and ovarian cancer syndrome with a high risk of early‐onset breast cancer. Whereas olaparib (OLA), an inhibitor of poly‐ADP‐ribose polymerase, has been applied as adjuvant therapy to those cancer patients, its effect on ovarian reproductive function remains unelucidated. Recently, a rat model (MUT; Brca1 (L63X/+) mutation) mimicking a human BRCA1 pathogenic variant has been established. Using this model, we evaluated the effects of OLA on ovarian reproductive function in comparison with the wild‐type (WT) rats. MUT showed a significantly reduced number of primordial follicles and subfertility in accordance with aging. Oxidative stress was significantly elevated in the young MUT granulosa cells (GCs) accompanied by increased mTOR but decreased PTEN signals. OLA administration in MUT further decreased primordial follicles, with gene set enrichment analysis, indicating upregulated DNA repair pathways. Furthermore, a combination of OLA and cyclophosphamide (CPA) induced empty primordial follicles, recognized as CPA‐induced severe ovarian toxicity. Whereas OLA + CPA caused greater reduction in primordial follicles both in MUT and WT in comparison with CPA alone, MUT ovaries were more susceptible to oxidative stress, potentially depleting primordial follicles via activation of GCs and inducing oocyte death due to accumulated DNA damage by OLA treatment. Our findings in this preclinical model underscore the importance of evaluating ovarian reserve prior to chemotherapy by performing reproductive consultation with female patients with BRCA1 pathogenic variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian ReservePhthalazinesBRCA1 ProteinBreast NeoplasmsAntineoplastic AgentsFemaleAnimalsRatsCyclophosphamideOxidative StressPiperazinesOvarian FollicleGranulosa CellsDisease Models, AnimalMutationHumansOvaryPTEN PhosphohydrolasePoly(ADP-ribose) Polymerase Inhibitors

Stichwörter der Autor:innen

BRCA1PARP inhibitoragingcyclophosphamidefertilityprimordial follicle

Substanzen

PhthalazinesBRCA1 ProteinolaparibCyclophosphamidePiperazinesAntineoplastic AgentsPTEN PhosphohydrolasePoly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Maternal and Perinatal Medicine, Nagoya University Hospital, Nagoya, Aichi, Japan.
  • Division of Animal Genetics, Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Division of Genome Engineering, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Department of Radiation Effects Research, Institute for Radiological Science, National Institutes for Quantum Science and Technology, Chiba, Japan.

ORCID-Profile: Yashiro Motooka, Hiroaki Kajiyama, Tatsuhiko Imaoka, Shinya Toyokuni

Förderung

  • Core Research for Evolutional Science and Technology
  • Japan Society for the Promotion of Science

Zitieren

APA

Kaseki, S., Sonehara, R., Motooka, Y., Tanaka, H., Nakamura, T., Osuka, S., Akatsuka, S., Kajiyama, H., Mashimo, T., Imaoka, T., & Toyokuni, S. (2025). Susceptibility of Brca1 ( L63X/+ ) rat to ovarian reserve dissipation by chemotherapeutic agents to breast cancer. Cancer Science, 116(4), 1139-1152. https://doi.org/10.1111/cas.16412

Vancouver

Kaseki S, Sonehara R, Motooka Y, Tanaka H, Nakamura T, Osuka S, et al. Susceptibility of Brca1 ( L63X/+ ) rat to ovarian reserve dissipation by chemotherapeutic agents to breast cancer. Cancer Science. 2025;116(4):1139-1152. doi:10.1111/cas.16412

BibTeX
@article{Kaseki2025,
  author = {Kaseki, Satoshi and Sonehara, Reina and Motooka, Yashiro and Tanaka, Hideaki and Nakamura, Tomoko and Osuka, Satoko and Akatsuka, Shinya and Kajiyama, Hiroaki and Mashimo, Tomoji and Imaoka, Tatsuhiko and Toyokuni, Shinya},
  title = {Susceptibility of Brca1 ( L63X/+ ) rat to ovarian reserve dissipation by chemotherapeutic agents to breast cancer},
  journal = {Cancer Science},
  year = {2025},
  volume = {116},
  number = {4},
  pages = {1139--1152},
  doi = {10.1111/cas.16412}
}
Kostenlos starten →